219 related articles for article (PubMed ID: 34019695)
1. HLA-DRB1*15:01 is a co-receptor for Epstein-Barr virus, linking genetic and environmental risk factors for multiple sclerosis.
Menegatti J; Schub D; Schäfer M; Grässer FA; Ruprecht K
Eur J Immunol; 2021 Sep; 51(9):2348-2350. PubMed ID: 34019695
[TBL] [Abstract][Full Text] [Related]
2. A meta-analysis of interaction between Epstein-Barr virus and HLA-DRB1*1501 on risk of multiple sclerosis.
Xiao D; Ye X; Zhang N; Ou M; Guo C; Zhang B; Liu Y; Wang M; Yang G; Jing C
Sci Rep; 2015 Dec; 5():18083. PubMed ID: 26656273
[TBL] [Abstract][Full Text] [Related]
3. Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosis.
Ziaei A; Solomon O; Casper TC; Waltz M; Weinstock-Guttman B; Aaen G; Wheeler Y; Graves J; Benson L; Gorman M; Rensel M; Mar S; Lotze T; Greenberg B; Chitnis T; Waldman AT; Krupp L; James JA; Hart J; Barcellos LF; Waubant E
Mult Scler; 2024 Mar; 30(3):308-315. PubMed ID: 38332747
[TBL] [Abstract][Full Text] [Related]
4. Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis.
Waubant E; Mowry EM; Krupp L; Chitnis T; Yeh EA; Kuntz N; Ness J; Belman A; Milazzo M; Gorman M; Weinstock-Guttman B; Rodriguez M; James JA
Mult Scler; 2013 Jun; 19(7):891-5. PubMed ID: 23232601
[TBL] [Abstract][Full Text] [Related]
5. HLA-DRB1 15:01 and Epstein-Barr virus in a multiple sclerosis patient with psoriasis, nasopharyngeal and breast cancers. Lessons for possible hidden links for autoimmunity and cancer.
Anagnostouli M; Anagnostoulis G; Katsavos S; Panagiotou M; Kararizou E; Davaki P
J Neurol Sci; 2014 Apr; 339(1-2):26-31. PubMed ID: 24576802
[TBL] [Abstract][Full Text] [Related]
6. Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis.
De Jager PL; Simon KC; Munger KL; Rioux JD; Hafler DA; Ascherio A
Neurology; 2008 Mar; 70(13 Pt 2):1113-8. PubMed ID: 18272866
[TBL] [Abstract][Full Text] [Related]
7. A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
Rubicz R; Yolken R; Drigalenko E; Carless MA; Dyer TD; Bauman L; Melton PE; Kent JW; Harley JB; Curran JE; Johnson MP; Cole SA; Almasy L; Moses EK; Dhurandhar NV; Kraig E; Blangero J; Leach CT; Göring HH
PLoS Genet; 2013; 9(1):e1003147. PubMed ID: 23326239
[TBL] [Abstract][Full Text] [Related]
8. Gender influence in EBV antibody response in multiple sclerosis patients from Kuwait.
Al-Temaimi R; Alroughani R; Jacob S; Al-Mulla F
J Neuroimmunol; 2015 Aug; 285():57-61. PubMed ID: 26198919
[TBL] [Abstract][Full Text] [Related]
9. Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15.
Zdimerova H; Murer A; Engelmann C; Raykova A; Deng Y; Gujer C; Rühl J; McHugh D; Caduff N; Naghavian R; Pezzino G; Capaul R; Zbinden A; Ferlazzo G; Lünemann JD; Martin R; Chatterjee B; Münz C
Eur J Immunol; 2021 Jan; 51(1):64-75. PubMed ID: 32949466
[TBL] [Abstract][Full Text] [Related]
10. Immune control of human γ-herpes infections.
Münz C
Semin Arthritis Rheum; 2024 Feb; 64S():152320. PubMed ID: 38007361
[TBL] [Abstract][Full Text] [Related]
11. Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
Tschochner M; Leary S; Cooper D; Strautins K; Chopra A; Clark H; Choo L; Dunn D; James I; Carroll WM; Kermode AG; Nolan D
PLoS One; 2016; 11(2):e0147567. PubMed ID: 26849221
[TBL] [Abstract][Full Text] [Related]
12. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.
Sargsyan SA; Shearer AJ; Ritchie AM; Burgoon MP; Anderson S; Hemmer B; Stadelmann C; Gattenlöhner S; Owens GP; Gilden D; Bennett JL
Neurology; 2010 Apr; 74(14):1127-35. PubMed ID: 20220124
[TBL] [Abstract][Full Text] [Related]
13. Epstein Barr virus infection and immune defense related to HLA-DR15: consequences for multiple sclerosis.
Olsson T
Eur J Immunol; 2021 Jan; 51(1):56-59. PubMed ID: 33350470
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus and multiple sclerosis: interaction with HLA.
Sundqvist E; Sundström P; Lindén M; Hedström AK; Aloisi F; Hillert J; Kockum I; Alfredsson L; Olsson T
Genes Immun; 2012 Jan; 13(1):14-20. PubMed ID: 21776012
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain.
Willis SN; Stadelmann C; Rodig SJ; Caron T; Gattenloehner S; Mallozzi SS; Roughan JE; Almendinger SE; Blewett MM; Brück W; Hafler DA; O'Connor KC
Brain; 2009 Dec; 132(Pt 12):3318-28. PubMed ID: 19638446
[TBL] [Abstract][Full Text] [Related]
16. Current and past Epstein-Barr virus infection in risk of initial CNS demyelination.
Lucas RM; Ponsonby AL; Dear K; Valery P; Pender MP; Burrows JM; Burrows SR; Chapman C; Coulthard A; Dwyer DE; Dwyer T; Kilpatrick T; Lay ML; McMichael AJ; Taylor BV; van der Mei IA; Williams D
Neurology; 2011 Jul; 77(4):371-9. PubMed ID: 21753179
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
Serafini B; Rosicarelli B; Veroni C; Mazzola GA; Aloisi F
J Virol; 2019 Dec; 93(24):. PubMed ID: 31578295
[TBL] [Abstract][Full Text] [Related]
18. Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis.
Engdahl E; Gustafsson R; Huang J; Biström M; Lima Bomfim I; Stridh P; Khademi M; Brenner N; Butt J; Michel A; Jons D; Hortlund M; Alonso-Magdalena L; Hedström AK; Flamand L; Ihira M; Yoshikawa T; Andersen O; Hillert J; Alfredsson L; Waterboer T; Sundström P; Olsson T; Kockum I; Fogdell-Hahn A
Front Immunol; 2019; 10():2715. PubMed ID: 32038605
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies.
Fernández-Menéndez S; Fernández-Morán M; Fernández-Vega I; Pérez-Álvarez A; Villafani-Echazú J
J Neurol Sci; 2016 Feb; 361():213-9. PubMed ID: 26810546
[TBL] [Abstract][Full Text] [Related]
20. EBNA-1 reactivity and HLA DRB1*1501 as statistically independent risk factors for multiple sclerosis: a case-control study.
Sundström P; Nyström L; Jidell E; Hallmans G
Mult Scler; 2008 Sep; 14(8):1120-2. PubMed ID: 18573815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]